Form 4 Syneos Health, Inc. For: May 06 Filed by: ADVENT INTERNATIONAL CORP/MA
Tweet
Share
E-mail| FORM 4 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 |
|
|||||||||||||||||||
| Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b). | |||||||||||||||||||||
1. Name and Address of Reporting Person
*
(Street)
|
2. Issuer Name
and
Ticker or Trading Symbol
Syneos Health, Inc. [ SYNH ] |
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
|
||||||||||||||||||||||||
|
3. Date of Earliest Transaction
(Month/Day/Year) 05/06/2021 | ||||||||||||||||||||||||||
|
4. If Amendment, Date of Original Filed
(Month/Day/Year) |
6. Individual or Joint/Group Filing (Check
Applicable Line)
|
|||||||||||||||||||||||||
| Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 1. Title of Security (Instr. 3) | 2. Transaction Date (Month/Day/Year) | 2A. Deemed Execution Date, if any (Month/Day/Year) | 3. Transaction Code (Instr. 8) | 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) | 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) | 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) | 7. Nature of Indirect Beneficial Ownership (Instr. 4) | |||
| Code | V | Amount | (A) or (D) | Price | ||||||
| Class A Common Stock | 05/06/2021 | S (1) | 3,791,652 (1) | D | $ 81.04 | 6,973,097 | I | See Notes (4) (5) | ||
| Class A Common Stock | 05/06/2021 | S (3) | 216,666 (2) | D | $ 81.04 | 6,756,431 (3) | I | See Notes (4) (5) | ||
|
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1. Title of Derivative Security (Instr. 3) | 2. Conversion or Exercise Price of Derivative Security | 3. Transaction Date (Month/Day/Year) | 3A. Deemed Execution Date, if any (Month/Day/Year) | 4. Transaction Code (Instr. 8) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) | 6. Date Exercisable and Expiration Date (Month/Day/Year) | 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) | 8. Price of Derivative Security (Instr. 5) | 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) | 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) | 11. Nature of Indirect Beneficial Ownership (Instr. 4) | ||||
| Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||||||
| See Exhibit 99.2 | 05/10/2021 | |
| ** Signature of Reporting Person | Date | |
| Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | ||
| * If the form is filed by more than one reporting person, see Instruction 4 (b)(v). | ||
| ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). | ||
| Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. | ||
| Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number. | ||
Exhibit 99.1
|
Name and Address of Reporting Person:
|
Advent International Corporation
|
|
Prudential Tower, 800 Boylston Street, Suite 3300
|
|
|
Boston, MA 02199-8069
|
|
|
Issuer Name and Ticker or Trading Symbol:
|
Syneos Health, Inc. [SYNH]
|
|
Date of Earliest Transaction Required to be Reported:
|
May 6, 2021
|
|
(Month/Day/Year)
|
Footnotes to Form 4
(1) Represents shares of Class A Common Stock (“Common Stock”) of Syneos Health, Inc. (the “Issuer”) sold in connection with a secondary offering of the
Issuer’s Common Stock (the “Offering”) by the following entities: 64,792 shares sold by Advent International GPE VIII-C Limited Partnership (“GPE VIII-C”) and 3,726,860 shares sold by Double Eagle Investor Holdings, L.P. (“Double Eagle Investor
Holdings”), of which: 773 shares were indirectly sold by Advent Partners GPE VII Limited Partnership, 1,980 shares were indirectly sold by Advent Partners GPE VII 2014 Limited Partnership, 1,828 shares were indirectly sold by Advent Partners GPE
VII-A Limited Partnership, 5,426 shares were indirectly sold by Advent Partners GPE VII-A 2014 Limited Partnership, 13,180 shares were indirectly sold by Advent Partners GPE VII (Cayman) Limited Partnership, 4,455 shares were indirectly sold by
Advent Partners GPE VII 2014 Cayman Limited Partnership, 3,484 shares were indirectly sold by Advent Partners GPE VII-A (Cayman) Limited Partnership, 18,067 shares were indirectly sold by Advent Partners GPE VII-B (Cayman) Limited Partnership, 3,144
shares were indirectly sold by Advent Partners GPE VII-A 2014 (Cayman) Limited Partnership (collectively, the “Advent Partners GPE VII Funds”); 165,005 shares were indirectly sold by Advent International GPE VII-A Limited Partnership, 366,092 shares
were indirectly sold by Advent International GPE VII-E Limited Partnership, 28,615 shares were indirectly sold by Advent International GPE VII-H Limited Partnership (collectively, the “GPE VII GP Funds”); 178,272 shares were indirectly sold by Advent
International GPE VII Limited Partnership, 508,241 shares were indirectly sold by Advent International GPE VII-B Limited Partnership, 161,513 shares were indirectly sold by Advent International GPE VII-C Limited Partnership, 106,735 shares were
indirectly sold by Advent International GPE VII-D Limited Partnership, 47,130 shares were indirectly sold by Advent International GPE VII-F Limited Partnership, 47,130 shares were indirectly sold by Advent International GPE VII-G Limited Partnership
(collectively, the “GPE VII GP S.a.r.l. Funds”); 120,104 shares were indirectly sold by Advent International GPE VIII Limited Partnership, 397,835 shares were indirectly sold by Advent International GPE VIII-B Limited Partnership, 141,171 shares were
indirectly sold by Advent International GPE VIII-B-1 Limited Partnership, 105,256 shares were indirectly sold by Advent International GPE VIII-B-2 Limited Partnership, 164,360 shares were indirectly sold by Advent International GPE VIII-B-3 Limited
Partnership, 55,411 shares were indirectly sold by Advent International GPE VIII-D Limited Partnership, 16,422 shares were indirectly sold by Advent International GPE VIII-F Limited Partnership, 145,482 shares were indirectly sold by Advent
International GPE VIII-H Limited Partnership, 135,283 shares were indirectly sold by Advent International GPE VIII-I Limited Partnership, 132,943 shares were indirectly sold by Advent International GPE VIII-J Limited Partnership (collectively, the
“GPE VIII GP S.a.r.l. Funds”); 281,720 shares were indirectly sold by Advent International GPE VIII-A Limited Partnership, 61,713 shares were indirectly sold by Advent International GPE VIII-E Limited Partnership, 104,668 shares were indirectly sold
by Advent International GPE VIII-G Limited Partnership, 57,603 shares were indirectly sold by Advent International GPE VIII-K Limited Partnership, 56,689 shares were indirectly sold by Advent International GPE VIII-L Limited Partnership
(collectively, the “GPE VIII GP Funds”); 27,679 shares were indirectly sold by Advent Partners GPE VIII Cayman Limited Partnership, 3,685 shares were indirectly sold by Advent Partners GPE VIII-A Cayman Limited Partnership, 47,354 shares were
indirectly sold by Advent Partners GPE VIII-B Cayman Limited Partnership, 4,645 shares were indirectly sold by Advent Partners GPE VIII Limited Partnership, and 5,767 shares were indirectly sold by Advent Partners GPE VIII-A Limited Partnership
(collectively, the “Advent Partners GPE VIII Funds”).
1
(2) Represents shares of Common Stock sold to the Issuer (the “Private Sale”) by the following entities: 3,702 shares sold by GPE VIII-C and 212,964 shares sold by Double Eagle Investor
Holdings, of which: 45 were indirectly sold by Advent Partners GPE VII Limited Partnership, 113 shares were indirectly sold by Advent Partners GPE VII 2014 Limited Partnership, 104 shares were indirectly sold by Advent Partners GPE VII-A Limited
Partnership, 310 shares were indirectly sold by Advent Partners GPE VII-A 2014 Limited Partnership, 753 shares were indirectly sold by Advent Partners GPE VII (Cayman) Limited Partnership, 255 shares were indirectly sold by Advent Partners GPE VII
2014 Cayman Limited Partnership, 199 shares were indirectly sold by Advent Partners GPE VII-A (Cayman) Limited Partnership, 1,033 shares indirectly sold by Advent Partners GPE VII-B (Cayman) Limited Partnership, 179 shares were indirectly sold by
Advent Partners GPE VII-A 2014 (Cayman) Limited Partnership; 9,429 shares were indirectly sold by Advent International GPE VII-A Limited Partnership, 20,919 shares were indirectly sold by Advent International GPE VII-E Limited Partnership, 1,636
shares were indirectly sold by Advent International GPE VII-H Limited Partnership; 10,187 shares were indirectly sold by Advent International GPE VII Limited Partnership, 29,039 shares were indirectly sold by Advent International GPE VII-B Limited
Partnership, 9,229 shares were indirectly sold by Advent International GPE VII-C Limited Partnership, 6,099 shares were indirectly sold by Advent International GPE VII-D Limited Partnership, 2,694 shares were indirectly sold by Advent International
GPE VII-F Limited Partnership, 2,694 shares were indirectly sold by Advent International GPE VII-G Limited Partnership; 6,863 shares were indirectly sold by Advent International GPE VIII Limited Partnership, 22,734 shares were indirectly sold by
Advent International GPE VIII-B Limited Partnership, 8,067 shares were indirectly sold by Advent International GPE VIII-B-1 Limited Partnership, 6,016 shares were indirectly sold by Advent International GPE VIII-B-2 Limited Partnership, 9,392 shares
were indirectly sold by Advent International GPE VIII-B-3 Limited Partnership, 3,166 shares were indirectly sold by Advent International GPE VIII-D Limited Partnership, 938 shares were indirectly sold by Advent International GPE VIII-F Limited
Partnership, 8,314 shares were indirectly sold by Advent International GPE VIII-H Limited Partnership, 7,730 shares were indirectly sold by Advent International GPE VIII-I Limited Partnership, 7,597 shares were indirectly sold by Advent International
GPE VIII-J Limited Partnership; 16,098 shares were indirectly sold by Advent International GPE VIII-A Limited Partnership, 3,526 shares were indirectly sold by Advent International GPE VIII-E Limited Partnership, 5,981 shares were indirectly sold by
Advent International GPE VIII-G Limited Partnership, 3,292 shares were indirectly sold by Advent International GPE VIII-K Limited Partnership, 3,239 shares were indirectly sold by Advent International GPE VIII-L Limited Partnership; 1,582 shares were
indirectly sold by Advent Partners GPE VIII Cayman Limited Partnership, 211 shares were indirectly sold by Advent Partners GPE VIII-A Cayman Limited Partnership, 2,706 shares were indirectly sold by Advent Partners GPE VIII-B Cayman Limited
Partnership, 265 shares were indirectly sold by Advent Partners GPE VIII Limited Partnership, and 330 shares were indirectly sold by Advent Partners GPE VIII-A Limited Partnership.
(3) Following the Offering and the Private Sale, Advent manages funds that collectively own 6,756,431 shares, which are represented as follows: 115,455 shares held directly by GPE VIII-C and
6,640,976 shares held directly by Double Eagle Investor Holdings, of which: 1,378 shares are indirectly owned by Advent Partners GPE VII Limited Partnership, 3,527 shares are indirectly owned by Advent Partners GPE VII 2014 Limited Partnership, 3,257
shares are indirectly owned by Advent Partners GPE VII-A Limited Partnership, 9,668 shares are indirectly owned by Advent Partners GPE VII-A 2014 Limited Partnership, 32,485 shares are indirectly owned by Advent Partners GPE VII (Cayman) Limited
Partnership, 7,939 shares are indirectly owned by Advent Partners GPE VII 2014 Cayman Limited Partnership, 6,209 shares are indirectly owned by Advent Partners GPE VII-A (Cayman) Limited Partnership, 32,194 shares are indirectly owned by Advent
Partners GPE VII-B (Cayman) Limited Partnership, 5,602 shares are indirectly owned by Advent Partners GPE VII-A 2014 (Cayman) Limited Partnership; 294,026 shares are indirectly owned by Advent International GPE VII-A Limited Partnership, 652,347
shares are indirectly owned by Advent International GPE VII-E Limited Partnership, 50,990 shares are indirectly owned by Advent International GPE VII-H Limited Partnership; 317,668 shares are indirectly owned by Advent International GPE VII Limited
Partnership, 905,648 shares are indirectly owned by Advent International GPE VII-B Limited Partnership, 287,804 shares are indirectly owned by Advent International GPE VII-C Limited Partnership, 190,193 shares are indirectly owned by Advent
International GPE VII-D Limited Partnership, 83,981 shares are indirectly owned by Advent International GPE VII-F Limited Partnership, 83,981 shares are indirectly owned by Advent International GPE VII-G Limited Partnership; 214,017 shares are
indirectly owned by Advent International GPE VIII Limited Partnership, 708,911 shares are indirectly owned by Advent International GPE VIII-B Limited Partnership, 251,556 shares are indirectly owned by Advent International GPE VIII-B-1 Limited
Partnership, 187,558 shares are indirectly owned by Advent International GPE VIII-B-2 Limited Partnership, 292,878 shares are indirectly owned by Advent International GPE VIII-B-3 Limited Partnership, 98,739 shares are indirectly owned by Advent
International GPE VIII-D Limited Partnership, 29,262 shares are indirectly owned by Advent International GPE VIII-F Limited Partnership, 259,237 shares are indirectly owned by Advent International GPE VIII-H Limited Partnership, 241,063 shares are
indirectly owned by Advent International GPE VIII-I Limited Partnership, 236,894 shares are indirectly owned by Advent International GPE VIII-J Limited Partnership; 502,003 shares are indirectly owned by Advent International GPE VIII-A Limited
Partnership, 109,968 shares are indirectly owned by Advent International GPE VIII-E Limited Partnership, 186,511 shares are indirectly owned by Advent International GPE VIII-G Limited Partnership, 102,644 shares are indirectly owned by Advent
International GPE VIII-K Limited Partnership, 101,015 shares are indirectly owned by Advent International GPE VIII-L Limited Partnership; 49,322 shares are indirectly owned by Advent Partners GPE VIII Cayman Limited Partnership, 6,567 shares are
indirectly owned by Advent Partners GPE VIII-A Cayman Limited Partnership, 77,278 shares are indirectly owned by Advent Partners GPE VIII-B Cayman Limited Partnership, 8,277 shares are indirectly owned by Advent Partners GPE VIII Limited Partnership,
and 10,276 shares are indirectly owned by Advent Partners GPE VIII-A Limited Partnership.
2
(4) Advent is the Sole Member of Double Eagle GP, LLC, which in turn is the General Partner of Double Eagle Investor Holdings. Advent is the Manager of Advent International GPE
VII, LLC (“GPE VII LLC”) and Advent International GPE VIII, LLC (“GPE VIII LLC”).
GPE VII, LLC is the General Partner of GPE VII GP S.a.r.l. (“GPE VII GP S.a.r.l.”), GPE VII GP Limited Partnership (“GPE VII GP”), and the Advent Partners GPE
VII Funds. GPE VII GP is the General Partner of the GPE VII GP Funds. GPE VII GP S.a.r.l. is the General Partner of the GPE VII GP S.a.r.l. Funds.
GPE VIII LLC is the General Partner of GPE VIII GP Limited Partnership (“GPE VIII GP”), GPE VIII GP S.a.r.l. (“GPE VIII GP S.a.r.l.”), and AP GPE VIII GP
Limited Partnership (“AP GPE VIII GP”). GPE VIII GP S.a.r.l. is the General Partner of the GPE VIII GP S.a.r.l. Funds and of GPE VIII-C. GPE VIII GP is the General Partner of the GPE VIII GP Funds. AP GPE VIII GP is the General Partner of the Advent
Partners GPE VIII Funds.
(5) Each of the entities named above are referred to herein as “Reporting Persons.” Each Reporting Person disclaims Section 16 beneficial ownership of the shares reported herein
except to the extent of its respective pecuniary interest therein, if any, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all the reported shares for purposes of Section 16 of the
Securities Exchange Act of 1934, as amended, or any other purpose.
3
Exhibit 99.2
Joint Filer Information
|
Name of Joint Filer:
|
Double Eagle Investor Holdings, L.P.
|
|
Address of Joint Filer:
|
c/o Advent International Corporation
|
|
Prudential Tower, 800 Boylston Street, Suite 3300
|
|
|
Boston, MA 02199-8069
|
|
|
Relationship of Joint Filer to Issuer:
|
10% Owner
|
|
Issuer Name and Ticker or Trading Symbol:
|
Syneos Health, Inc. [SYNH]
|
|
Date of Earliest Transaction Required
|
|
|
to be Reported (Month/Day/Year):
|
May 6, 2021
|
|
Designated Filer:
|
Advent International Corporation
|
Signature:
DOUBLE EAGLE INVESTOR HOLDINGS, L.P.
By: Double Eagle GP, LLC, its General Partner
By: Advent International Corporation, its Sole Member
By:
|
/s/ Michael Ristaino
|
|
|
Name: Michael Ristaino
|
|
|
Title: Vice President of Finance - Fund Administration
|
May 10, 2021
Date
Page 1 of 48
Joint Filer Information
|
Name of Joint Filer:
|
Double Eagle GP, LLC
|
|
Address of Joint Filer:
|
c/o Advent International Corporation
|
|
Prudential Tower, 800 Boylston Street, Suite 3300
|
|
|
Boston, MA 02199-8069
|
|
|
Relationship of Joint Filer to Issuer:
|
10% Owner
|
|
Issuer Name and Ticker or Trading Symbol:
|
Syneos Health, Inc. [SYNH]
|
|
Date of Earliest Transaction Required
|
|
|
to be Reported (Month/Day/Year):
|
May 6, 2021
|
|
Designated Filer:
|
Advent International Corporation
|
Signature:
DOUBLE EAGLE GP, LLC
By: Advent International Corporation, its Sole Member
By:
|
/s/ Michael Ristaino
|
|
|
Name: Michael Ristaino
|
|
|
Title: Vice President of Finance - Fund Administration
|
May 10, 2021
Date
Page 2 of 48
Joint Filer Information
|
Name of Joint Filer:
|
Advent International GPE VIII-C Limited Partnership
|
|
Address of Joint Filer:
|
c/o Advent International Corporation
|
|
Prudential Tower, 800 Boylston Street, Suite 3300
|
|
|
Boston, MA 02199-8069
|
|
|
Relationship of Joint Filer to Issuer:
|
10% Owner
|
|
Issuer Name and Ticker or Trading Symbol:
|
Syneos Health, Inc. [SYNH]
|
|
Date of Earliest Transaction Required
|
|
|
to be Reported (Month/Day/Year):
|
May 6, 2021
|
|
Designated Filer:
|
Advent International Corporation
|
Signature:
|
ADVENT INTERNATIONAL GPE VIII-C LIMITED PARTNERSHIP
|
||
|
By: GPE VIII GP S.à r.l., its General Partner
|
||
|
By: Advent International GPE VIII, LLC, its Manager
|
/s/ Jarlyth Gibson
|
|
|
By: Advent International Corporation, its Manager
|
Jarlyth Gibson, Manager
|
By:
|
/s/ Michael Ristaino
|
|
|
Name: Michael Ristaino
|
|
|
Title: Vice President of Finance - Fund Administration
|
May 10, 2021
Date
Page 3 of 48
Joint Filer Information
|
Name of Joint Filer:
|
GPE VIII GP S.à r.l.
|
|
Address of Joint Filer:
|
c/o Advent International Corporation
|
|
Prudential Tower, 800 Boylston Street, Suite 3300
|
|
|
Boston, MA 02199-8069
|
|
|
Relationship of Joint Filer to Issuer:
|
10% Owner
|
|
Issuer Name and Ticker or Trading Symbol:
|
Syneos Health, Inc. [SYNH]
|
|
Date of Earliest Transaction Required
|
|
|
to be Reported (Month/Day/Year):
|
May 6, 2021
|
|
Designated Filer:
|
Advent International Corporation
|
Signature:
|
GPE VIII GP S.à r.l.
|
||
|
By: Advent International GPE VIII, LLC, its Manager
|
/s/ Jarlyth Gibson
|
|
|
By: Advent International Corporation, its Manager
|
Jarlyth Gibson, Manager
|
By:
|
/s/ Michael Ristaino
|
|
|
Name: Michael Ristaino
|
|
|
Title: Vice President of Finance - Fund Administration
|
May 10, 2021
Date
Page 4 of 48
Joint Filer Information
|
Name of Joint Filer:
|
GPE VIII GP Limited Partnership
|
|
Address of Joint Filer:
|
c/o Advent International Corporation
|
|
Prudential Tower, 800 Boylston Street, Suite 3300
|
|
|
Boston, MA 02199-8069
|
|
|
Relationship of Joint Filer to Issuer:
|
10% Owner
|
|
Issuer Name and Ticker or Trading Symbol:
|
Syneos Health, Inc. [SYNH]
|
|
Date of Earliest Transaction Required
|
|
|
to be Reported (Month/Day/Year):
|
May 6, 2021
|
|
Designated Filer:
|
Advent International Corporation
|
Signature:
GPE VIII GP LIMITED PARTNERSHIP
By: Advent International GPE VIII, LLC, its General Partner
By: Advent International Corporation, its Manager
By:
|
/s/ Michael Ristaino
|
|
|
Name: Michael Ristaino
|
|
|
Title: Vice President of Finance - Fund Administration
|
May 10, 2021
Date
Page 5 of 48
Joint Filer Information
|
Name of Joint Filer:
|
Advent International GPE VIII, LLC
|
|
Address of Joint Filer:
|
c/o Advent International Corporation
|
|
Prudential Tower, 800 Boylston Street, Suite 3300
|
|
|
Boston, MA 02199-8069
|
|
|
Relationship of Joint Filer to Issuer:
|
10% Owner
|
|
Issuer Name and Ticker or Trading Symbol:
|
Syneos Health, Inc. [SYNH]
|
|
Date of Earliest Transaction Required
|
|
|
to be Reported (Month/Day/Year):
|
May 6, 2021
|
|
Designated Filer:
|
Advent International Corporation
|
Signature:
ADVENT INTERNATIONAL GPE VIII, LLC
By: Advent International Corporation, its Manager
By:
|
/s/ Michael Ristaino
|
|
|
Name: Michael Ristaino
|
|
|
Title: Vice President of Finance - Fund Administration
|
May 10, 2021
Date
Page 6 of 48
Joint Filer Information
|
Name of Joint Filer:
|
GPE VII GP S.à r.l.
|
|
Address of Joint Filer:
|
c/o Advent International Corporation
|
|
Prudential Tower, 800 Boylston Street, Suite 3300
|
|
|
Boston, MA 02199-8069
|
|
|
Relationship of Joint Filer to Issuer:
|
10% Owner
|
|
Issuer Name and Ticker or Trading Symbol:
|
Syneos Health, Inc. [SYNH]
|
|
Date of Earliest Transaction Required
|
|
|
to be Reported (Month/Day/Year):
|
May 6, 2021
|
|
Designated Filer:
|
Advent International Corporation
|
Signature:
|
GPE VII GP S.à r.l.
|
||
|
By: Advent International GPE VIII, LLC, its Manager
|
/s/ Jarlyth Gibson
|
|
|
By: Advent International Corporation, its Manager
|
Jarlyth Gibson, Manager
|
By:
|
/s/ Michael Ristaino
|
|
|
Name: Michael Ristaino
|
|
|
Title: Vice President of Finance - Fund Administration
|
May 10, 2021
Date
Page 7 of 48
Joint Filer Information
|
Name of Joint Filer:
|
GPE VII GP Limited Partnership
|
|
Address of Joint Filer:
|
c/o Advent International Corporation
|
|
Prudential Tower, 800 Boylston Street, Suite 3300
|
|
|
Boston, MA 02199-8069
|
|
|
Relationship of Joint Filer to Issuer:
|
10% Owner
|
|
Issuer Name and Ticker or Trading Symbol:
|
Syneos Health, Inc. [SYNH]
|
|
Date of Earliest Transaction Required
|
|
|
to be Reported (Month/Day/Year):
|
May 6, 2021
|
|
Designated Filer:
|
Advent International Corporation
|
Signature:
GPE VII GP LIMITED PARTNERSHIP
By: Advent International GPE VII, LLC, its General Partner
By: Advent International Corporation, its Manager
By:
|
/s/ Michael Ristaino
|
|
|
Name: Michael Ristaino
|
|
|
Title: Vice President of Finance - Fund Administration
|
May 10, 2021
Date
Page 8 of 48
Joint Filer Information
|
Name of Joint Filer:
|
Advent International GPE VII, LLC
|
|
Address of Joint Filer:
|
c/o Advent International Corporation
|
|
Prudential Tower, 800 Boylston Street, Suite 3300
|
|
|
Boston, MA 02199-8069
|
|
|
Relationship of Joint Filer to Issuer:
|
10% Owner
|
|
Issuer Name and Ticker or Trading Symbol:
|
Syneos Health, Inc. [SYNH]
|
|
Date of Earliest Transaction Required
|
|
|
to be Reported (Month/Day/Year):
|
May 6, 2021
|
|
Designated Filer:
|
Advent International Corporation
|
Signature:
ADVENT INTERNATIONAL GPE VII, LLC
By: Advent International Corporation, its Manager
By:
|
/s/ Michael Ristaino
|
|
|
Name: Michael Ristaino
|
|
|
Title: Vice President of Finance - Fund Administration
|
May 10, 2021
Date
Page 9 of 48
Joint Filer Information
|
Name of Joint Filer:
|
AP GPE VIII GP Limited Partnership
|
|
Address of Joint Filer:
|
c/o Advent International Corporation
|
|
Prudential Tower, 800 Boylston Street, Suite 3300
|
|
|
Boston, MA 02199-8069
|
|
|
Relationship of Joint Filer to Issuer:
|
10% Owner
|
|
Issuer Name and Ticker or Trading Symbol:
|
Syneos Health, Inc. [SYNH]
|
|
Date of Earliest Transaction Required
|
|
|
to be Reported (Month/Day/Year):
|
May 6, 2021
|
|
Designated Filer:
|
Advent International Corporation
|
Signature:
AP GPE VIII GP LIMITED PARTNERSHIP
By: Advent International GPE VIII, LLC, its General Partner
By: Advent International Corporation, its Manager
By:
|
/s/ Michael Ristaino
|
|
|
Name: Michael Ristaino
|
|
|
Title: Vice President of Finance - Fund Administration
|
May 10, 2021
Date
Page 10 of 48
Joint Filer Information
|
Name of Joint Filer:
|
Advent Partners GPE VIII Cayman Limited Partnership
|
|
Address of Joint Filer:
|
c/o Advent International Corporation
|
|
Prudential Tower, 800 Boylston Street, Suite 3300
|
|
|
Boston, MA 02199-8069
|
|
|
Relationship of Joint Filer to Issuer:
|
10% Owner
|
|
Issuer Name and Ticker or Trading Symbol:
|
Syneos Health, Inc. [SYNH]
|
|
Date of Earliest Transaction Required
|
|
|
to be Reported (Month/Day/Year):
|
May 6, 2021
|
|
Designated Filer:
|
Advent International Corporation
|
Signature:
ADVENT PARTNERS GPE VIII CAYMAN LIMITED PARTNERSHIP
By: AP GPE VIII GP Limited Partnership, its General Partner
By: Advent International GPE VIII, LLC, its General Partner
By: Advent International Corporation, its Manager
By:
|
/s/ Michael Ristaino
|
|
|
Name: Michael Ristaino
|
|
|
Title: Vice President of Finance - Fund Administration
|
May 10, 2021
Date
Page 11 of 48
Joint Filer Information
|
Name of Joint Filer:
|
Advent Partners GPE VIII-B Cayman Limited Partnership
|
|
Address of Joint Filer:
|
c/o Advent International Corporation
|
|
Prudential Tower, 800 Boylston Street, Suite 3300
|
|
|
Boston, MA 02199-8069
|
|
|
Relationship of Joint Filer to Issuer:
|
10% Owner
|
|
Issuer Name and Ticker or Trading Symbol:
|
Syneos Health, Inc. [SYNH]
|
|
Date of Earliest Transaction Required
|
|
|
to be Reported (Month/Day/Year):
|
May 6, 2021
|
|
Designated Filer:
|
Advent International Corporation
|
Signature:
ADVENT PARTNERS GPE VIII-B CAYMAN LIMITED PARTNERSHIP
By: AP GPE VIII GP Limited Partnership, its General Partner
By: Advent International GPE VIII, LLC, its General Partner
By: Advent International Corporation, its Manager
By:
|
/s/ Michael Ristaino
|
|
|
Name: Michael Ristaino
|
|
|
Title: Vice President of Finance - Fund Administration
|
May 10, 2021
Date
Page 12 of 48
Joint Filer Information
|
Name of Joint Filer:
|
Advent Partners GPE VIII Limited Partnership
|
|
Address of Joint Filer:
|
c/o Advent International Corporation
|
|
Prudential Tower, 800 Boylston Street, Suite 3300
|
|
|
Boston, MA 02199-8069
|
|
|
Relationship of Joint Filer to Issuer:
|
10% Owner
|
|
Issuer Name and Ticker or Trading Symbol:
|
Syneos Health, Inc. [SYNH]
|
|
Date of Earliest Transaction Required
|
|
|
to be Reported (Month/Day/Year):
|
May 6, 2021
|
|
Designated Filer:
|
Advent International Corporation
|
Signature:
ADVENT PARTNERS GPE VIII LIMITED PARTNERSHIP
By: AP GPE VIII GP Limited Partnership, its General Partner
By: Advent International GPE VIII, LLC, its General Partner
By: Advent International Corporation, its Manager
By:
|
/s/ Michael Ristaino
|
|
|
Name: Michael Ristaino
|
|
|
Title: Vice President of Finance - Fund Administration
|
May 10, 2021
Date
Page 13 of 48
Joint Filer Information
|
Name of Joint Filer:
|
Advent Partners GPE VIII-A Limited Partnership
|
|
Address of Joint Filer:
|
c/o Advent International Corporation
|
|
Prudential Tower, 800 Boylston Street, Suite 3300
|
|
|
Boston, MA 02199-8069
|
|
|
Relationship of Joint Filer to Issuer:
|
10% Owner
|
|
Issuer Name and Ticker or Trading Symbol:
|
Syneos Health, Inc. [SYNH]
|
|
Date of Earliest Transaction Required
|
|
|
to be Reported (Month/Day/Year):
|
May 6, 2021
|
|
Designated Filer:
|
Advent International Corporation
|
Signature:
ADVENT PARTNERS GPE VIII-A LIMITED PARTNERSHIP
By: AP GPE VIII GP Limited Partnership, its General Partner
By: Advent International GPE VIII, LLC, its General Partner
By: Advent International Corporation, its Manager
By:
|
/s/ Michael Ristaino
|
|
|
Name: Michael Ristaino
|
|
|
Title: Vice President of Finance - Fund Administration
|
May 10, 2021
Date
Page 14 of 48
Joint Filer Information
|
Name of Joint Filer:
|
Advent Partners GPE VIII-A Cayman Limited Partnership
|
|
Address of Joint Filer:
|
c/o Advent International Corporation
|
|
Prudential Tower, 800 Boylston Street, Suite 3300
|
|
|
Boston, MA 02199-8069
|
|
|
Relationship of Joint Filer to Issuer:
|
10% Owner
|
|
Issuer Name and Ticker or Trading Symbol:
|
Syneos Health, Inc. [SYNH]
|
|
Date of Earliest Transaction Required
|
|
|
to be Reported (Month/Day/Year):
|
May 6, 2021
|
|
Designated Filer:
|
Advent International Corporation
|
Signature:
ADVENT PARTNERS GPE VIII-A CAYMAN LIMITED PARTNERSHIP
By: AP GPE VIII GP Limited Partnership, its General Partner
By: Advent International GPE VIII, LLC, its General Partner
By: Advent International Corporation, its Manager
By:
|
/s/ Michael Ristaino
|
|
|
Name: Michael Ristaino
|
|
|
Title: Vice President of Finance - Fund Administration
|
May 10, 2021
Date
Page 15 of 48
Joint Filer Information
|
Name of Joint Filer:
|
Advent International GPE VII-A Limited Partnership
|
|
Address of Joint Filer:
|
c/o Advent International Corporation
|
|
Prudential Tower, 800 Boylston Street, Suite 3300
|
|
|
Boston, MA 02199-8069
|
|
|
Relationship of Joint Filer to Issuer:
|
10% Owner
|
|
Issuer Name and Ticker or Trading Symbol:
|
Syneos Health, Inc. [SYNH]
|
|
Date of Earliest Transaction Required
|
|
|
to be Reported (Month/Day/Year):
|
May 6, 2021
|
|
Designated Filer:
|
Advent International Corporation
|
Signature:
ADVENT INTERNATIONAL GPE VII-A LIMITED PARTNERSHIP
By: GPE VII GP Limited Partnership, its General Partner
By: Advent International GPE VII, LLC, its General Partner
By: Advent International Corporation, its Manager
By:
|
/s/ Michael Ristaino
|
|
|
Name: Michael Ristaino
|
|
|
Title: Vice President of Finance - Fund Administration
|
May 10, 2021
Date
Page 16 of 48
Joint Filer Information
|
Name of Joint Filer:
|
Advent International GPE VII-E Limited Partnership
|
|
Address of Joint Filer:
|
c/o Advent International Corporation
|
|
Prudential Tower, 800 Boylston Street, Suite 3300
|
|
|
Boston, MA 02199-8069
|
|
|
Relationship of Joint Filer to Issuer:
|
10% Owner
|
|
Issuer Name and Ticker or Trading Symbol:
|
Syneos Health, Inc. [SYNH]
|
|
Date of Earliest Transaction Required
|
|
|
to be Reported (Month/Day/Year):
|
May 6, 2021
|
|
Designated Filer:
|
Advent International Corporation
|
Signature:
ADVENT INTERNATIONAL GPE VII-E LIMITED PARTNERSHIP
By: GPE VII GP Limited Partnership, its General Partner
By: Advent International GPE VII, LLC, its General Partner
By: Advent International Corporation, its Manager
By:
|
/s/ Michael Ristaino
|
|
|
Name: Michael Ristaino
|
|
|
Title: Vice President of Finance - Fund Administration
|
May 10, 2021
Date
Page 17 of 48
Joint Filer Information
|
Name of Joint Filer:
|
Advent International GPE VII-H Limited Partnership
|
|
Address of Joint Filer:
|
c/o Advent International Corporation
|
|
Prudential Tower, 800 Boylston Street, Suite 3300
|
|
|
Boston, MA 02199-8069
|
|
|
Relationship of Joint Filer to Issuer:
|
10% Owner
|
|
Issuer Name and Ticker or Trading Symbol:
|
Syneos Health, Inc. [SYNH]
|
|
Date of Earliest Transaction Required
|
|
|
to be Reported (Month/Day/Year):
|
May 6, 2021
|
|
Designated Filer:
|
Advent International Corporation
|
Signature:
ADVENT INTERNATIONAL GPE VII-H LIMITED PARTNERSHIP
By: GPE VII GP Limited Partnership, its General Partner
By: Advent International GPE VII, LLC, its General Partner
By: Advent International Corporation, its Manager
By:
|
/s/ Michael Ristaino
|
|
|
Name: Michael Ristaino
|
|
|
Title: Vice President of Finance - Fund Administration
|
May 10, 2021
Date
Page 18 of 48
Joint Filer Information
|
Name of Joint Filer:
|
Advent Partners GPE VII Limited Partnership
|
|
Address of Joint Filer:
|
c/o Advent International Corporation
|
|
Prudential Tower, 800 Boylston Street, Suite 3300
|
|
|
Boston, MA 02199-8069
|
|
|
Relationship of Joint Filer to Issuer:
|
10% Owner
|
|
Issuer Name and Ticker or Trading Symbol:
|
Syneos Health, Inc. [SYNH]
|
|
Date of Earliest Transaction Required
|
|
|
to be Reported (Month/Day/Year):
|
May 6, 2021
|
|
Designated Filer:
|
Advent International Corporation
|
Signature:
ADVENT PARTNERS GPE VII LIMITED PARTNERSHIP
By: Advent International GPE VII, LLC, its General Partner
By: Advent International Corporation, its Manager
By:
|
/s/ Michael Ristaino
|
|
|
Name: Michael Ristaino
|
|
|
Title: Vice President of Finance - Fund Administration
|
May 10, 2021
Date
Page 19 of 48
Joint Filer Information
|
Name of Joint Filer:
|
Advent Partners GPE VII 2014 Limited Partnership
|
|
Address of Joint Filer:
|
c/o Advent International Corporation
|
|
Prudential Tower, 800 Boylston Street, Suite 3300
|
|
|
Boston, MA 02199-8069
|
|
|
Relationship of Joint Filer to Issuer:
|
10% Owner
|
|
Issuer Name and Ticker or Trading Symbol:
|
Syneos Health, Inc. [SYNH]
|
|
Date of Earliest Transaction Required
|
|
|
to be Reported (Month/Day/Year):
|
May 6, 2021
|
|
Designated Filer:
|
Advent International Corporation
|
Signature:
ADVENT PARTNERS GPE VII 2014 LIMITED PARTNERSHIP
By: Advent International GPE VII, LLC, its General Partner
By: Advent International Corporation, its Manager
By:
|
/s/ Michael Ristaino
|
|
|
Name: Michael Ristaino
|
|
|
Title: Vice President of Finance - Fund Administration
|
May 10, 2021
Date
Page 20 of 48
Joint Filer Information
|
Name of Joint Filer:
|
Advent Partners GPE VII-A Limited Partnership
|
|
Address of Joint Filer:
|
c/o Advent International Corporation
|
|
Prudential Tower, 800 Boylston Street, Suite 3300
|
|
|
Boston, MA 02199-8069
|
|
|
Relationship of Joint Filer to Issuer:
|
10% Owner
|
|
Issuer Name and Ticker or Trading Symbol:
|
Syneos Health, Inc. [SYNH]
|
|
Date of Earliest Transaction Required
|
|
|
to be Reported (Month/Day/Year):
|
May 6, 2021
|
|
Designated Filer:
|
Advent International Corporation
|
Signature:
ADVENT PARTNERS GPE VII-A LIMITED PARTNERSHIP
By: Advent International GPE VII, LLC, its General Partner
By: Advent International Corporation, its Manager
By:
|
/s/ Michael Ristaino
|
|
|
Name: Michael Ristaino
|
|
|
Title: Vice President of Finance - Fund Administration
|
May 10, 2021
Date
Page 21 of 48
Joint Filer Information
|
Name of Joint Filer:
|
Advent Partners GPE VII-A 2014 Limited Partnership
|
|
Address of Joint Filer:
|
c/o Advent International Corporation
|
|
Prudential Tower, 800 Boylston Street, Suite 3300
|
|
|
Boston, MA 02199-8069
|
|
|
Relationship of Joint Filer to Issuer:
|
10% Owner
|
|
Issuer Name and Ticker or Trading Symbol:
|
Syneos Health, Inc. [SYNH]
|
|
Date of Earliest Transaction Required
|
|
|
to be Reported (Month/Day/Year):
|
May 6, 2021
|
|
Designated Filer:
|
Advent International Corporation
|
Signature:
ADVENT PARTNERS GPE VII-A 2014 LIMITED PARTNERSHIP
By: Advent International GPE VII, LLC, its General Partner
By: Advent International Corporation, its Manager
By:
|
/s/ Michael Ristaino
|
|
|
Name: Michael Ristaino
|
|
|
Title: Vice President of Finance - Fund Administration
|
May 10, 2021
Date
Page 22 of 48
Joint Filer Information
|
Name of Joint Filer:
|
Advent Partners GPE VII Cayman Limited Partnership
|
|
Address of Joint Filer:
|
c/o Advent International Corporation
|
|
Prudential Tower, 800 Boylston Street, Suite 3300
|
|
|
Boston, MA 02199-8069
|
|
|
Relationship of Joint Filer to Issuer:
|
10% Owner
|
|
Issuer Name and Ticker or Trading Symbol:
|
Syneos Health, Inc. [SYNH]
|
|
Date of Earliest Transaction Required
|
|
|
to be Reported (Month/Day/Year):
|
May 6, 2021
|
|
Designated Filer:
|
Advent International Corporation
|
Signature:
ADVENT PARTNERS GPE VII CAYMAN LIMITED PARTNERSHIP
By: Advent International GPE VII, LLC, its General Partner
By: Advent International Corporation, its Manager
By:
|
/s/ Michael Ristaino
|
|
|
Name: Michael Ristaino
|
|
|
Title: Vice President of Finance - Fund Administration
|
May 10, 2021
Date
Page 23 of 48
Joint Filer Information
|
Name of Joint Filer:
|
Advent Partners GPE VII 2014 Cayman Limited Partnership
|
|
Address of Joint Filer:
|
c/o Advent International Corporation
|
|
Prudential Tower, 800 Boylston Street, Suite 3300
|
|
|
Boston, MA 02199-8069
|
|
|
Relationship of Joint Filer to Issuer:
|
10% Owner
|
|
Issuer Name and Ticker or Trading Symbol:
|
Syneos Health, Inc. [SYNH]
|
|
Date of Earliest Transaction Required
|
|
|
to be Reported (Month/Day/Year):
|
May 6, 2021
|
|
Designated Filer:
|
Advent International Corporation
|
Signature:
ADVENT PARTNERS GPE VII 2014 CAYMAN LIMITED PARTNERSHIP
By: Advent International GPE VII, LLC, its General Partner
By: Advent International Corporation, its Manager
By:
|
/s/ Michael Ristaino
|
|
|
Name: Michael Ristaino
|
|
|
Title: Vice President of Finance - Fund Administration
|
May 10, 2021
Date
Page 24 of 48
Joint Filer Information
|
Name of Joint Filer:
|
Advent Partners GPE VII-A Cayman Limited Partnership
|
|
Address of Joint Filer:
|
c/o Advent International Corporation
|
|
Prudential Tower, 800 Boylston Street, Suite 3300
|
|
|
Boston, MA 02199-8069
|
|
|
Relationship of Joint Filer to Issuer:
|
10% Owner
|
|
Issuer Name and Ticker or Trading Symbol:
|
Syneos Health, Inc. [SYNH]
|
|
Date of Earliest Transaction Required
|
|
|
to be Reported (Month/Day/Year):
|
May 6, 2021
|
|
Designated Filer:
|
Advent International Corporation
|
Signature:
ADVENT PARTNERS GPE VII-A CAYMAN LIMITED PARTNERSHIP
By: Advent International GPE VII, LLC, its General Partner
By: Advent International Corporation, its Manager
By:
|
/s/ Michael Ristaino
|
|
|
Name: Michael Ristaino
|
|
|
Title: Vice President of Finance - Fund Administration
|
May 10, 2021
Date
Page 25 of 48
Joint Filer Information
|
Name of Joint Filer:
|
Advent Partners GPE VII-B Cayman Limited Partnership
|
|
Address of Joint Filer:
|
c/o Advent International Corporation
|
|
Prudential Tower, 800 Boylston Street, Suite 3300
|
|
|
Boston, MA 02199-8069
|
|
|
Relationship of Joint Filer to Issuer:
|
10% Owner
|
|
Issuer Name and Ticker or Trading Symbol:
|
Syneos Health, Inc. [SYNH]
|
|
Date of Earliest Transaction Required
|
|
|
to be Reported (Month/Day/Year):
|
May 6, 2021
|
|
Designated Filer:
|
Advent International Corporation
|
Signature:
ADVENT PARTNERS GPE VII-B CAYMAN LIMITED PARTNERSHIP
By: Advent International GPE VII, LLC, its General Partner
By: Advent International Corporation, its Manager
By:
|
/s/ Michael Ristaino
|
|
|
Name: Michael Ristaino
|
|
|
Title: Vice President of Finance - Fund Administration
|
May 10, 2021
Date
Page 26 of 48
Joint Filer Information
|
Name of Joint Filer:
|
Advent Partners GPE VII-A 2014 Cayman Limited Partnership
|
|
Address of Joint Filer:
|
c/o Advent International Corporation
|
|
Prudential Tower, 800 Boylston Street, Suite 3300
|
|
|
Boston, MA 02199-8069
|
|
|
Relationship of Joint Filer to Issuer:
|
10% Owner
|
|
Issuer Name and Ticker or Trading Symbol:
|
Syneos Health, Inc. [SYNH]
|
|
Date of Earliest Transaction Required
|
|
|
to be Reported (Month/Day/Year):
|
May 6, 2021
|
|
Designated Filer:
|
Advent International Corporation
|
Signature:
ADVENT PARTNERS GPE VII-A 2014 CAYMAN LIMITED PARTNERSHIP
By: Advent International GPE VII, LLC, its General Partner
By: Advent International Corporation, its Manager
By:
|
/s/ Michael Ristaino
|
|
|
Name: Michael Ristaino
|
|
|
Title: Vice President of Finance - Fund Administration
|
May 10, 2021
Date
Page 27 of 48
Joint Filer Information
|
Name of Joint Filer:
|
Advent International GPE VIII Limited Partnership
|
|
Address of Joint Filer:
|
c/o Advent International Corporation
|
|
Prudential Tower, 800 Boylston Street, Suite 3300
|
|
|
Boston, MA 02199-8069
|
|
|
Relationship of Joint Filer to Issuer:
|
10% Owner
|
|
Issuer Name and Ticker or Trading Symbol:
|
Syneos Health, Inc. [SYNH]
|
|
Date of Earliest Transaction Required
|
|
|
to be Reported (Month/Day/Year):
|
May 6, 2021
|
|
Designated Filer:
|
Advent International Corporation
|
Signature:
ADVENT INTERNATIONAL GPE VIII LIMITED PARTNERSHIP
By: GPE VII GP S.à r.l., its general partner
|
By: Advent International GPE VIII, LLC, its Manager
|
/s/ Jarlyth Gibson
|
|
|
By: Advent International Corporation, its Manager
|
Jarlyth Gibson, Manager
|
By:
|
/s/ Michael Ristaino
|
|
|
Name: Michael Ristaino
|
|
|
Title: Vice President of Finance - Fund Administration
|
May 10, 2021
Date
Page 28 of 48
Joint Filer Information
|
Name of Joint Filer:
|
Advent International GPE VIII-B Limited Partnership
|
|
Address of Joint Filer:
|
c/o Advent International Corporation
|
|
Prudential Tower, 800 Boylston Street, Suite 3300
|
|
|
Boston, MA 02199-8069
|
|
|
Relationship of Joint Filer to Issuer:
|
10% Owner
|
|
Issuer Name and Ticker or Trading Symbol:
|
Syneos Health, Inc. [SYNH]
|
|
Date of Earliest Transaction Required
|
|
|
to be Reported (Month/Day/Year):
|
May 6, 2021
|
|
Designated Filer:
|
Advent International Corporation
|
Signature:
ADVENT INTERNATIONAL GPE VIII-B LIMITED PARTNERSHIP
By: GPE VII GP S.à r.l., its general partner
|
By: Advent International GPE VIII, LLC, its Manager
|
/s/ Jarlyth Gibson
|
|
|
By: Advent International Corporation, its Manager
|
Jarlyth Gibson, Manager
|
By:
|
/s/ Michael Ristaino
|
|
|
Name: Michael Ristaino
|
|
|
Title: Vice President of Finance - Fund Administration
|
May 10, 2021
Date
Page 29 of 48
Joint Filer Information
|
Name of Joint Filer:
|
Advent International GPE VIII-B-1 Limited Partnership
|
|
Address of Joint Filer:
|
c/o Advent International Corporation
|
|
Prudential Tower, 800 Boylston Street, Suite 3300
|
|
|
Boston, MA 02199-8069
|
|
|
Relationship of Joint Filer to Issuer:
|
10% Owner
|
|
Issuer Name and Ticker or Trading Symbol:
|
Syneos Health, Inc. [SYNH]
|
|
Date of Earliest Transaction Required
|
|
|
to be Reported (Month/Day/Year):
|
May 6, 2021
|
|
Designated Filer:
|
Advent International Corporation
|
Signature:
ADVENT INTERNATIONAL GPE VIII-B-1 LIMITED PARTNERSHIP
By: GPE VII GP S.à r.l., its general partner
|
By: Advent International GPE VIII, LLC, its Manager
|
/s/ Jarlyth Gibson
|
|
|
By: Advent International Corporation, its Manager
|
Jarlyth Gibson, Manager
|
By:
|
/s/ Michael Ristaino
|
|
|
Name: Michael Ristaino
|
|
|
Title: Vice President of Finance - Fund Administration
|
May 10, 2021
Date
Page 30 of 48
Joint Filer Information
|
Name of Joint Filer:
|
Advent International GPE VIII-B-2 Limited Partnership
|
|
Address of Joint Filer:
|
c/o Advent International Corporation
|
|
Prudential Tower, 800 Boylston Street, Suite 3300
|
|
|
Boston, MA 02199-8069
|
|
|
Relationship of Joint Filer to Issuer:
|
10% Owner
|
|
Issuer Name and Ticker or Trading Symbol:
|
Syneos Health, Inc. [SYNH]
|
|
Date of Earliest Transaction Required
|
|
|
to be Reported (Month/Day/Year):
|
May 6, 2021
|
|
Designated Filer:
|
Advent International Corporation
|
Signature:
ADVENT INTERNATIONAL GPE VIII-B-2 LIMITED PARTNERSHIP
By: GPE VII GP S.à r.l., its general partner
|
By: Advent International GPE VIII, LLC, its Manager
|
/s/ Jarlyth Gibson
|
|
|
By: Advent International Corporation, its Manager
|
Jarlyth Gibson, Manager
|
By:
|
/s/ Michael Ristaino
|
|
|
Name: Michael Ristaino
|
|
|
Title: Vice President of Finance - Fund Administration
|
May 10, 2021
Date
Page 31 of 48
Joint Filer Information
|
Name of Joint Filer:
|
Advent International GPE VIII-B-3 Limited Partnership
|
|
Address of Joint Filer:
|
c/o Advent International Corporation
|
|
Prudential Tower, 800 Boylston Street, Suite 3300
|
|
|
Boston, MA 02199-8069
|
|
|
Relationship of Joint Filer to Issuer:
|
10% Owner
|
|
Issuer Name and Ticker or Trading Symbol:
|
Syneos Health, Inc. [SYNH]
|
|
Date of Earliest Transaction Required
|
|
|
to be Reported (Month/Day/Year):
|
May 6, 2021
|
|
Designated Filer:
|
Advent International Corporation
|
Signature:
ADVENT INTERNATIONAL GPE VIII-B-3 LIMITED PARTNERSHIP
By: GPE VII GP S.à r.l., its general partner
|
By: Advent International GPE VIII, LLC, its Manager
|
/s/ Jarlyth Gibson
|
|
|
By: Advent International Corporation, its Manager
|
Jarlyth Gibson, Manager
|
By:
|
/s/ Michael Ristaino
|
|
|
Name: Michael Ristaino
|
|
|
Title: Vice President of Finance - Fund Administration
|
May 10, 2021
Date
Page 32 of 48
Joint Filer Information
|
Name of Joint Filer:
|
Advent International GPE VIII-D Limited Partnership
|
|
Address of Joint Filer:
|
c/o Advent International Corporation
|
|
Prudential Tower, 800 Boylston Street, Suite 3300
|
|
|
Boston, MA 02199-8069
|
|
|
Relationship of Joint Filer to Issuer:
|
10% Owner
|
|
Issuer Name and Ticker or Trading Symbol:
|
Syneos Health, Inc. [SYNH]
|
|
Date of Earliest Transaction Required
|
|
|
to be Reported (Month/Day/Year):
|
May 6, 2021
|
|
Designated Filer:
|
Advent International Corporation
|
Signature:
ADVENT INTERNATIONAL GPE VIII-D LIMITED PARTNERSHIP
By: GPE VII GP S.à r.l., its general partner
|
By: Advent International GPE VIII, LLC, its Manager
|
/s/ Jarlyth Gibson
|
|
|
By: Advent International Corporation, its Manager
|
Jarlyth Gibson, Manager
|
By:
|
/s/ Michael Ristaino
|
|
|
Name: Michael Ristaino
|
|
|
Title: Vice President of Finance - Fund Administration
|
May 10, 2021
Date
Page 33 of 48
Joint Filer Information
|
Name of Joint Filer:
|
Advent International GPE VIII-F Limited Partnership
|
|
Address of Joint Filer:
|
c/o Advent International Corporation
|
|
Prudential Tower, 800 Boylston Street, Suite 3300
|
|
|
Boston, MA 02199-8069
|
|
|
Relationship of Joint Filer to Issuer:
|
10% Owner
|
|
Issuer Name and Ticker or Trading Symbol:
|
Syneos Health, Inc. [SYNH]
|
|
Date of Earliest Transaction Required
|
|
|
to be Reported (Month/Day/Year):
|
May 6, 2021
|
|
Designated Filer:
|
Advent International Corporation
|
Signature:
ADVENT INTERNATIONAL GPE VIII-F LIMITED PARTNERSHIP
By: GPE VII GP S.à r.l., its general partner
|
By: Advent International GPE VIII, LLC, its Manager
|
/s/ Jarlyth Gibson
|
|
|
By: Advent International Corporation, its Manager
|
Jarlyth Gibson, Manager
|
By:
|
/s/ Michael Ristaino
|
|
|
Name: Michael Ristaino
|
|
|
Title: Vice President of Finance - Fund Administration
|
May 10, 2021
Date
Page 34 of 48
Joint Filer Information
|
Name of Joint Filer:
|
Advent International GPE VIII-H Limited Partnership
|
|
Address of Joint Filer:
|
c/o Advent International Corporation
|
|
Prudential Tower, 800 Boylston Street, Suite 3300
|
|
|
Boston, MA 02199-8069
|
|
|
Relationship of Joint Filer to Issuer:
|
10% Owner
|
|
Issuer Name and Ticker or Trading Symbol:
|
Syneos Health, Inc. [SYNH]
|
|
Date of Earliest Transaction Required
|
|
|
to be Reported (Month/Day/Year):
|
May 6, 2021
|
|
Designated Filer:
|
Advent International Corporation
|
Signature:
ADVENT INTERNATIONAL GPE VIII-H LIMITED PARTNERSHIP
By: GPE VII GP S.à r.l., its general partner
|
By: Advent International GPE VIII, LLC, its Manager
|
/s/ Jarlyth Gibson
|
|
|
By: Advent International Corporation, its Manager
|
Jarlyth Gibson, Manager
|
By:
|
/s/ Michael Ristaino
|
|
|
Name: Michael Ristaino
|
|
|
Title: Vice President of Finance - Fund Administration
|
May 10, 2021
Date
Page 35 of 48
Joint Filer Information
|
Name of Joint Filer:
|
Advent International GPE VIII-I Limited Partnership
|
|
Address of Joint Filer:
|
c/o Advent International Corporation
|
|
Prudential Tower, 800 Boylston Street, Suite 3300
|
|
|
Boston, MA 02199-8069
|
|
|
Relationship of Joint Filer to Issuer:
|
10% Owner
|
|
Issuer Name and Ticker or Trading Symbol:
|
Syneos Health, Inc. [SYNH]
|
|
Date of Earliest Transaction Required
|
|
|
to be Reported (Month/Day/Year):
|
May 6, 2021
|
|
Designated Filer:
|
Advent International Corporation
|
Signature:
ADVENT INTERNATIONAL GPE VIII-I LIMITED PARTNERSHIP
By: GPE VII GP S.à r.l., its general partner
|
By: Advent International GPE VIII, LLC, its Manager
|
/s/ Jarlyth Gibson
|
|
|
By: Advent International Corporation, its Manager
|
Jarlyth Gibson, Manager
|
By:
|
/s/ Michael Ristaino
|
|
|
Name: Michael Ristaino
|
|
|
Title: Vice President of Finance - Fund Administration
|
May 10, 2021
Date
Page 36 of 48
Joint Filer Information
|
Name of Joint Filer:
|
Advent International GPE VIII-J Limited Partnership
|
|
Address of Joint Filer:
|
c/o Advent International Corporation
|
|
Prudential Tower, 800 Boylston Street, Suite 3300
|
|
|
Boston, MA 02199-8069
|
|
|
Relationship of Joint Filer to Issuer:
|
10% Owner
|
|
Issuer Name and Ticker or Trading Symbol:
|
Syneos Health, Inc. [SYNH]
|
|
Date of Earliest Transaction Required
|
|
|
to be Reported (Month/Day/Year):
|
May 6, 2021
|
|
Designated Filer:
|
Advent International Corporation
|
Signature:
ADVENT INTERNATIONAL GPE VIII-J LIMITED PARTNERSHIP
By: GPE VII GP S.à r.l., its general partner
|
By: Advent International GPE VIII, LLC, its Manager
|
/s/ Jarlyth Gibson
|
|
|
By: Advent International Corporation, its Manager
|
Jarlyth Gibson, Manager
|
By:
|
/s/ Michael Ristaino
|
|
|
Name: Michael Ristaino
|
|
|
Title: Vice President of Finance - Fund Administration
|
May 10, 2021
Date
Page 37 of 48
Joint Filer Information
|
Name of Joint Filer:
|
Advent International GPE VIII-A Limited Partnership
|
|
Address of Joint Filer:
|
c/o Advent International Corporation
|
|
Prudential Tower, 800 Boylston Street, Suite 3300
|
|
|
Boston, MA 02199-8069
|
|
|
Relationship of Joint Filer to Issuer:
|
10% Owner
|
|
Issuer Name and Ticker or Trading Symbol:
|
Syneos Health, Inc. [SYNH]
|
|
Date of Earliest Transaction Required
|
|
|
to be Reported (Month/Day/Year):
|
May 6, 2021
|
|
Designated Filer:
|
Advent International Corporation
|
Signature:
ADVENT INTERNATIONAL GPE VIII-A LIMITED PARTNERSHIP
By: GPE VIII GP Limited Partnership, its General Partner
By: Advent International GPE VIII, LLC, its General Partner
By: Advent International Corporation, its Manager
By:
|
/s/ Michael Ristaino
|
|
|
Name: Michael Ristaino
|
|
|
Title: Vice President of Finance - Fund Administration
|
May 10, 2021
Date
Page 38 of 48
Joint Filer Information
|
Name of Joint Filer:
|
Advent International GPE VIII-E Limited Partnership
|
|
Address of Joint Filer:
|
c/o Advent International Corporation
|
|
Prudential Tower, 800 Boylston Street, Suite 3300
|
|
|
Boston, MA 02199-8069
|
|
|
Relationship of Joint Filer to Issuer:
|
10% Owner
|
|
Issuer Name and Ticker or Trading Symbol:
|
Syneos Health, Inc. [SYNH]
|
|
Date of Earliest Transaction Required
|
|
|
to be Reported (Month/Day/Year):
|
May 6, 2021
|
|
Designated Filer:
|
Advent International Corporation
|
Signature:
ADVENT INTERNATIONAL GPE VIII-E LIMITED PARTNERSHIP
By: GPE VIII GP Limited Partnership, its General Partner
By: Advent International GPE VIII, LLC, its General Partner
By: Advent International Corporation, its Manager
By:
|
/s/ Michael Ristaino
|
|
|
Name: Michael Ristaino
|
|
|
Title: Vice President of Finance - Fund Administration
|
May 10, 2021
Date
Page 39 of 48
Joint Filer Information
|
Name of Joint Filer:
|
Advent International GPE VIII-G Limited Partnership
|
|
Address of Joint Filer:
|
c/o Advent International Corporation
|
|
Prudential Tower, 800 Boylston Street, Suite 3300
|
|
|
Boston, MA 02199-8069
|
|
|
Relationship of Joint Filer to Issuer:
|
10% Owner
|
|
Issuer Name and Ticker or Trading Symbol:
|
Syneos Health, Inc. [SYNH]
|
|
Date of Earliest Transaction Required
|
|
|
to be Reported (Month/Day/Year):
|
May 6, 2021
|
|
Designated Filer:
|
Advent International Corporation
|
Signature:
ADVENT INTERNATIONAL GPE VIII-G LIMITED PARTNERSHIP
By: GPE VIII GP Limited Partnership, its General Partner
By: Advent International GPE VIII, LLC, its General Partner
By: Advent International Corporation, its Manager
By:
|
/s/ Michael Ristaino
|
|
|
Name: Michael Ristaino
|
|
|
Title: Vice President of Finance - Fund Administration
|
May 10, 2021
Date
Page 40 of 48
Joint Filer Information
|
Name of Joint Filer:
|
Advent International GPE VIII-K Limited Partnership
|
|
Address of Joint Filer:
|
c/o Advent International Corporation
|
|
Prudential Tower, 800 Boylston Street, Suite 3300
|
|
|
Boston, MA 02199-8069
|
|
|
Relationship of Joint Filer to Issuer:
|
10% Owner
|
|
Issuer Name and Ticker or Trading Symbol:
|
Syneos Health, Inc. [SYNH]
|
|
Date of Earliest Transaction Required
|
|
|
to be Reported (Month/Day/Year):
|
May 6, 2021
|
|
Designated Filer:
|
Advent International Corporation
|
Signature:
ADVENT INTERNATIONAL GPE VIII-K LIMITED PARTNERSHIP
By: GPE VIII GP Limited Partnership, its General Partner
By: Advent International GPE VIII, LLC, its General Partner
By: Advent International Corporation, its Manager
By:
|
/s/ Michael Ristaino
|
|
|
Name: Michael Ristaino
|
|
|
Title: Vice President of Finance - Fund Administration
|
May 10, 2021
Date
Page 41 of 48
Joint Filer Information
|
Name of Joint Filer:
|
Advent International GPE VIII-L Limited Partnership
|
|
Address of Joint Filer:
|
c/o Advent International Corporation
|
|
Prudential Tower, 800 Boylston Street, Suite 3300
|
|
|
Boston, MA 02199-8069
|
|
|
Relationship of Joint Filer to Issuer:
|
10% Owner
|
|
Issuer Name and Ticker or Trading Symbol:
|
Syneos Health, Inc. [SYNH]
|
|
Date of Earliest Transaction Required
|
|
|
to be Reported (Month/Day/Year):
|
May 6, 2021
|
|
Designated Filer:
|
Advent International Corporation
|
Signature:
ADVENT INTERNATIONAL GPE VIII-L LIMITED PARTNERSHIP
By: GPE VIII GP Limited Partnership, its General Partner
By: Advent International GPE VIII, LLC, its General Partner
By: Advent International Corporation, its Manager
By:
|
/s/ Michael Ristaino
|
|
|
Name: Michael Ristaino
|
|
|
Title: Vice President of Finance - Fund Administration
|
May 10, 2021
Date
Page 42 of 48
Joint Filer Information
|
Name of Joint Filer:
|
Advent International GPE VII Limited Partnership
|
|
Address of Joint Filer:
|
c/o Advent International Corporation
|
|
Prudential Tower, 800 Boylston Street, Suite 3300
|
|
|
Boston, MA 02199-8069
|
|
|
Relationship of Joint Filer to Issuer:
|
10% Owner
|
|
Issuer Name and Ticker or Trading Symbol:
|
Syneos Health, Inc. [SYNH]
|
|
Date of Earliest Transaction Required
|
|
|
to be Reported (Month/Day/Year):
|
May 6, 2021
|
|
Designated Filer:
|
Advent International Corporation
|
Signature:
ADVENT INTERNATIONAL GPE VII LIMITED PARTNERSHIP
By: GPE VII GP S.à r.l., its general partner
|
By: Advent International GPE VII, LLC, its Manager
|
/s/ Jarlyth Gibson
|
|
|
By: Advent International Corporation, its Manager
|
Jarlyth Gibson, Manager
|
By:
|
/s/ Michael Ristaino
|
|
|
Name: Michael Ristaino
|
|
|
Title: Vice President of Finance - Fund Administration
|
May 10, 2021
Date
Page 43 of 48
Joint Filer Information
|
Name of Joint Filer:
|
Advent International GPE VII-B Limited Partnership
|
|
Address of Joint Filer:
|
c/o Advent International Corporation
|
|
Prudential Tower, 800 Boylston Street, Suite 3300
|
|
|
Boston, MA 02199-8069
|
|
|
Relationship of Joint Filer to Issuer:
|
10% Owner
|
|
Issuer Name and Ticker or Trading Symbol:
|
Syneos Health, Inc. [SYNH]
|
|
Date of Earliest Transaction Required
|
|
|
to be Reported (Month/Day/Year):
|
May 6, 2021
|
|
Designated Filer:
|
Advent International Corporation
|
Signature:
ADVENT INTERNATIONAL GPE VII-B LIMITED PARTNERSHIP
By: GPE VII GP S.à r.l., its general partner
|
By: Advent International GPE VII, LLC, its Manager
|
/s/ Jarlyth Gibson
|
|
|
By: Advent International Corporation, its Manager
|
Jarlyth Gibson, Manager
|
By:
|
/s/ Michael Ristaino
|
|
|
Name: Michael Ristaino
|
|
|
Title: Vice President of Finance - Fund Administration
|
May 10, 2021
Date
Page 44 of 48
Joint Filer Information
|
Name of Joint Filer:
|
Advent International GPE VII-C Limited Partnership
|
|
Address of Joint Filer:
|
c/o Advent International Corporation
|
|
Prudential Tower, 800 Boylston Street, Suite 3300
|
|
|
Boston, MA 02199-8069
|
|
|
Relationship of Joint Filer to Issuer:
|
10% Owner
|
|
Issuer Name and Ticker or Trading Symbol:
|
Syneos Health, Inc. [SYNH]
|
|
Date of Earliest Transaction Required
|
|
|
to be Reported (Month/Day/Year):
|
May 6, 2021
|
|
Designated Filer:
|
Advent International Corporation
|
Signature:
ADVENT INTERNATIONAL GPE VII-C LIMITED PARTNERSHIP
By: GPE VII GP S.à r.l., its general partner
|
By: Advent International GPE VII, LLC, its Manager
|
/s/ Jarlyth Gibson
|
|
|
By: Advent International Corporation, its Manager
|
Jarlyth Gibson, Manager
|
By:
|
/s/ Michael Ristaino
|
|
|
Name: Michael Ristaino
|
|
|
Title: Vice President of Finance - Fund Administration
|
May 10, 2021
Date
Page 45 of 48
Joint Filer Information
|
Name of Joint Filer:
|
Advent International GPE VII-D Limited Partnership
|
|
Address of Joint Filer:
|
c/o Advent International Corporation
|
|
Prudential Tower, 800 Boylston Street, Suite 3300
|
|
|
Boston, MA 02199-8069
|
|
|
Relationship of Joint Filer to Issuer:
|
10% Owner
|
|
Issuer Name and Ticker or Trading Symbol:
|
Syneos Health, Inc. [SYNH]
|
|
Date of Earliest Transaction Required
|
|
|
to be Reported (Month/Day/Year):
|
May 6, 2021
|
|
Designated Filer:
|
Advent International Corporation
|
Signature:
ADVENT INTERNATIONAL GPE VII-D LIMITED PARTNERSHIP
By: GPE VII GP S.à r.l., its general partner
|
By: Advent International GPE VII, LLC, its Manager
|
/s/ Jarlyth Gibson
|
|
|
By: Advent International Corporation, its Manager
|
Jarlyth Gibson, Manager
|
By:
|
/s/ Michael Ristaino
|
|
|
Name: Michael Ristaino
|
|
|
Title: Vice President of Finance - Fund Administration
|
May 10, 2021
Date
Page 46 of 48
Joint Filer Information
|
Name of Joint Filer:
|
Advent International GPE VII-F Limited Partnership
|
|
Address of Joint Filer:
|
c/o Advent International Corporation
|
|
Prudential Tower, 800 Boylston Street, Suite 3300
|
|
|
Boston, MA 02199-8069
|
|
|
Relationship of Joint Filer to Issuer:
|
10% Owner
|
|
Issuer Name and Ticker or Trading Symbol:
|
Syneos Health, Inc. [SYNH]
|
|
Date of Earliest Transaction Required
|
|
|
to be Reported (Month/Day/Year):
|
May 6, 2021
|
|
Designated Filer:
|
Advent International Corporation
|
Signature:
ADVENT INTERNATIONAL GPE VII-F LIMITED PARTNERSHIP
By: GPE VII GP S.à r.l., its general partner
|
By: Advent International GPE VII, LLC, its Manager
|
/s/ Jarlyth Gibson
|
|
|
By: Advent International Corporation, its Manager
|
Jarlyth Gibson, Manager
|
By:
|
/s/ Michael Ristaino
|
|
|
Name: Michael Ristaino
|
|
|
Title: Vice President of Finance - Fund Administration
|
May 10, 2021
Date
Page 47 of 48
Joint Filer Information
|
Name of Joint Filer:
|
Advent International GPE VII-G Limited Partnership
|
|
Address of Joint Filer:
|
c/o Advent International Corporation
|
|
Prudential Tower, 800 Boylston Street, Suite 3300
|
|
|
Boston, MA 02199-8069
|
|
|
Relationship of Joint Filer to Issuer:
|
10% Owner
|
|
Issuer Name and Ticker or Trading Symbol:
|
Syneos Health, Inc. [SYNH]
|
|
Date of Earliest Transaction Required
|
|
|
to be Reported (Month/Day/Year):
|
May 6, 2021
|
|
Designated Filer:
|
Advent International Corporation
|
Signature:
ADVENT INTERNATIONAL GPE VII-G LIMITED PARTNERSHIP
By: GPE VII GP S.à r.l., its general partner
|
By: Advent International GPE VII, LLC, its Manager
|
/s/ Jarlyth Gibson
|
|
|
By: Advent International Corporation, its Manager
|
Jarlyth Gibson, Manager
|
By:
|
/s/ Michael Ristaino
|
|
|
Name: Michael Ristaino
|
|
|
Title: Vice President of Finance - Fund Administration
|
May 10, 2021
Date
Page 48 of 48
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Local Students From Orange Mound, Collierville, Whitehaven, Hickory Hill, Frayser, and South Memphis Gather at Ruth's Chris to Learn Financial Wisdom & the Stock Market
- Katana Cloud Inventory Named Winner of 2024 RetailTech Breakthrough Awards
- Apprio To Support FEMA’s Center for Domestic Preparedness Under $39M Contract
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
